Université de Montréal , Montréal , Canada
Mon 13 11:55
ENS3.4
Stroke Risk in Childhood, Adolescent, and Young Adult (CAYA) Cancer Survivors who Received Cranial Radiotherapy- results of local audit.
Université de Montréal , Montréal , Canada
Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK
Mon 13 13:01
OP2.3
Vitamin B12 deficiency alters leptin DNA methylation and lipid metabolism in the human placenta
Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK
The Christie NHS Foundation Trust, Manchester, UK
Mon 13 11:40
ENS3.3
Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer.
The Christie NHS Foundation Trust, Manchester, UK
Chelsea and Westminster Hospital, London, UK
Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland (RCSI), Dublin, UK
Mon 13 15:30
OC2.5
Androgen Mediated Metabolic Perturbation in Endocrine Resistant Breast Cancer
Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland (RCSI), Dublin, UK
Norfolk and Norwich University Hospitals NHS Trust , Norwich, UK
Tue 14 17:30
HDI2.3
De-escalate LT4 therapy in overtreated patients?
Norfolk and Norwich University Hospitals NHS Trust , Norwich, UK
Glasgow, United Kingdom
Mon 13 11:40
ENS1.3
I-CAH: a platform for data collection and network activities
Glasgow, United Kingdom
Mon 13 11:50
ENS1.4
Imperial College London, London, United Kingdom
Tue 14 15:00
OC6.1
Reduction of SGLT2 protein levels inhibits cortisol secretion through regulation of cytokine secretion
Imperial College London, London, United Kingdom
University of South Wales, Cardiff, UK
Mon 13 15:45
OC1.6
Management of Vitamin D Deficiency in Primary Hyperparathyroidism: A Systematic Literature Review and Meta-Analysis
University of South Wales, Cardiff, UK
London, UK
University of Edinburgh, Edinburgh, UK
Tue 14 16:15
OC5.6
11βHSD1 inhibition improves cardiac function compared to standard therapy in a translational pig mode through regulation of extracellular matrix
University of Edinburgh, Edinburgh, UK
University of Leicester, Leicester, UK
Tue 14 16:15
OC7.6
Shallow Whole Genome Sequencing (sWGS) as an Aiding Tool in Monitoring of Thyroid Cancer
University of Leicester, Leicester, UK
Queen Mary University of London, London, UK
Tue 14 13:56
OP5.3
Adrenal insufficiency can be associated with biallelic mutations in porphyria genes
Queen Mary University of London, London, UK
Queen Mary University of London, London, UK
Imperial College, London, UK
Tue 14 12:30
S3.3
Novel treatment approaches for breast and/or prostate cancer
Imperial College, London, UK
University of Exeter, Exeter, United Kingdom
Wed 15 10:50
ENS6.1
GLP-1 analogues for obesity: how do we prioritise patients?
Glasgow, UK
University of Exeter, Exeter, United Kingdom
London, United Kingdom
Guys & St Thomas NHS Trust, London, UK
Freeman Hospital , Newcastle Upon Tyne
UCL, London, UK
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Tue 14 17:15
NS3.3
Nurse Survey results
UCLH London, London, UK
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Institute for Cardiovascular Prevention
Tue 14 11:30
S2.1
ER stress in metabolic disease – mechanisms and treatments
Institute for Cardiovascular Prevention
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Tue 14 13:40
OP5.1
Nocturnal Metyrapone Administration for Cortisol Suppression in MACS: Tolerability and Impact on Metabolic Outcomes
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
King's College London, London, UK
Mon 13 09:10
WIN1.1
University of Chicago, Chicago, USA
Mon 13 13:25
PL1.1
Plenary 1: Are we restoring thyroid hormone signaling in patients with hypothyroidism?
University of Chicago, Chicago, USA
University of Glasgow, Glasgow, UK
Tue 14 16:00
OC5.5
Identification of MicroRNAs Targeting the Mineralocorticoid Receptor with Therapeutic Potential in Vascular Cognitive Impairment
University of Glasgow, Glasgow, UK
University of Birmingham, Birmingham, UK
Indiana School of Medicine, Indiana, USA
PeopleWith
Tue 14 17:05
NS3.2
Guy's and St Thomas' NHS Foundation Trust, London, UK
University of Exeter, Exeter, UK
Wed 15 14:50
ESD1.1
University of Birmingham, Birmingham, UK
Tue 14 15:00
OC7.1
A copper-based metabolite of disulfiram upregulates sodium iodide symporter (NIS) gene expression to enhance thyroidal uptake of radionuclides in vivo
University of Birmingham, Birmingham, UK
Genomics England, London, UK
University of Sheffield, Sheffield, UK
Tue 14 11:30
S3.1
Managing impacts of androgen deprivation therapy on bones
University of Sheffield, Sheffield, UK
Imperial College London
University of East Anglia, Norwich, UK
Mon 13 14:30
OC1.1
Vitamin D metabolites are associated with overuse musculoskeletal and bone stress injury in young adults
University of East Anglia, Norwich, UK
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 14 10:55
ENS5.1
Update on the national registry for phaeochromocytoma and paraganglioma and ACC
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 14 11:05
ENS5.2
Q&A
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Queen Mary University, London, UK
Mon 13 16:25
PR1.1
Queen Mary University of London , London, UK
Mon 13 13:55
PL2.1
Plenary 2: With a little help from my friends: Melanocortin Receptors and their accessory proteins in health and disease
Queen Mary University of London , London, UK
University of Edinburgh, Edinburgh, United Kingdom
Tue 14 17:00
LOE1.1
Steroids and the Cardiovascular System
University of Edinburgh, Edinburgh, United Kingdom
George Elliot Hospital, Nuneaton, UK
Wed 15 13:03
OP8.2
Subcutaneous Levothyroxine as an alternative long-term treatment for refractory hypothyroidism: A case report
George Elliot Hospital, Nuneaton, UK
Yong Loo Lin School of Medicine, Singapore, Singapore
Tue 14 15:45
OC7.4
The Effectiveness of Radioactive Iodine versus Thyroidectomy for Paediatric Grave’s Disease: A systematic review and meta-analysis.
Yong Loo Lin School of Medicine, Singapore, UK
Yong Loo Lin School of Medicine, Singapore, Singapore
University of Edinburgh, Edinburgh, UK
Tue 14 15:45
OC6.4
Human brown adipose tissue activity is regulated by the parasympathetic nervous system
University of Edinburgh, Edinburgh, UK
Mary Mediatrix Medical Center, Lipa City, Philippines
Tue 14 13:13
OP4.2
Primary thyroid sarcoma: a case report
Mary Mediatrix Medical Center, Lipa City, Philippines
Imperial
Monash University, Melbourne, Australia
Tue 14 15:45
OC5.4
Mild weight loss and activation of RAAS in gene-edited mice with a E958A knock-in mutation in the AF2-LBD domain of the mineralocorticoid receptor gene
Monash University, Melbourne, Australia
Imperial College London, London, UK
Tue 14 10:55
TAA1.1
Alex's Osteoblast : Revitalising Teaching During Covid
Imperial College London, London, UK
University of Cambridge , Cambridge , UK
Mon 13 11:50
ENS2.3
Glucocorticoid-induced osteoporosis: the state of the art in the era of anabolics
University of Cambridge , Cambridge , UK
Government Office for Science
Wed 15 14:50
ECS1.1
Listening and learning - how podcasting is more than a communication tool
Government Office for Science
Cardiff, Wales
Wed 15 11:00
ENS8.3
King's College Hospital, London, UK
Wed 15 13:19
OP7.4
Primary ovarian failure after 131I-metaiodobenzylguanide (MIBG) therapy
King's College Hospital, London, UK
King's College London, London, UK
Tue 14 18:15
HDI2.6
St Bartholomew’s Hospital, London, UK
Wed 15 09:45
S6.2
Reducing the queue for adrenal vein sampling
St Bartholomew’s Hospital, London, UK
University of Edinburgh, Edinburgh, UK
Mon 13 11:50
ENS4.3
King’s College London, London, UK
Mon 13 15:30
OC1.5
CTNNB1 pathogenic variants can cause an autosomal dominant osteoporosis-pseudoglioma-like syndrome: a new form of osteogenesis imperfecta?
King’s College London, London, UK
Tue 14 12:00
S1.2
Targeted therapies for monogenic bone disorders and lessons for commoner disease
King’s College London, London, UK
Birmingham, UK
Mon 13 09:45
CMW1.1
University of Cambridge , Cambridge , UK
Tue 14 17:15
HDI2.2
London, United Kingdom
Wed 15 10:50
ENS6.1
GLP-1 analogues for obesity: how do we prioritise patients?
Glasgow, UK
University of Exeter, Exeter, United Kingdom
London, United Kingdom
Guys & St Thomas NHS Trust, London, UK
Imperial College London, London, UK
Mon 13 15:15
OC2.4
Communication Between Peri-Prostatic Adipocytes and Epithelial Cells Drives Prostate Cancer Aggressivity in Obese Men
Imperial College London, London, UK
University of Leeds, Leeds, UK
Mon 13 11:50
ENS4.3
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Mon 13 14:45
OC3.2
Long-term outcomes of non-operated non-functioning pituitary macroadenomas – results from the UK NFPA consortium
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Royal Veterinary College, London, UK
Tue 14 15:30
OC7.3
Influence of tyrosine availability on TSH-dependent cell proliferation and gene transcription in rat FRTL-5 thyroid cells
Royal Veterinary College, London, UK
University of Aberdeen, Aberdeen
Imperial College , London, UK
Tue 14 08:30
PL4.1
Plenary 4: Living with Polycystic Ovary Syndrome: Concepts and Consequences
Imperial College , London, UK
Queen Elizabeth University Hospital, Glasgow, UK
Guy's and St Thomas' Trust, London, UK
Wed 15 13:03
OP7.2
Peptide Receptor Radiotherapy (PRRT) for well- differentiated metastatic Paraganglioma and Phaeochromocytomas (PPGL).
Guy's and St Thomas' Trust, London, UK
Parathyroid UK , Devon, UK
Centre for Health and Life Sciences- Coventry University, Coventry, UK
Tue 14 16:00
OC6.5
Increased risk of obesity programmed by in utero exposure to maternal obesity: the effects of miR-505-5p in the hypothalamus.
Centre for Health and Life Sciences- Coventry University, Coventry, UK
Royal Veterinary College, London, UK
Mon 13 12:45
OP2.1
Insulin resistance in macrophages impacts cholesterol biosynthesis and interferon gene expression and reduces foam cell formation capacity
Royal Veterinary College, London, UK
King's College London, London, UK
Tue 14 15:30
OC6.3
Sex hormone contribution to sex differences in a mouse model of beta cell endoplasmic reticulum (ER) stress.
King's College London, London, UK
endocrinologist at Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Tue 14 18:00
HDI2.5
Do an annual review in a patient with Turner's Syndrome?
endocrinologist at Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Imperial College London, London, UK
Mon 13 15:00
OC4.3
Self-administering post-cycle therapy is associated with biochemical gonadal recovery in men stopping anabolic-androgenic steroid use.
Imperial College London, London, UK
Association for Multiple Endocrine Neoplasia Disorders, Southborough, UK
Wed 15 12:00
RET1.4
Life with a RET gene change
Association for Multiple Endocrine Neoplasia Disorders, Southborough, UK
University of Cambridge, Cambridge, UK
Cumming School of Medicine, University of Calgary, Calgary, Canada
Wed 15 13:11
OP8.3
Unsuspected autonomous adrenal cortisol excess and primary aldosteronism accurately diagnosed by NP59 scanning after discordant adrenal vein sampling
Cumming School of Medicine, University of Calgary, Calgary, Canada
MRC Laboratory of Molecular Biology , Cambridge
Tue 14 17:00
BSW2.1
How to use structural biology to advance your endocrine research
MRC Laboratory of Molecular Biology , Cambridge
Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome Trust-MRC; Institute of Metabolic Science, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK
Wed 15 12:55
OP8.1
Real-world experience with 11C-methionine PET co-registered with MRI in the management of acromegaly – Insights from a single reference centre 12 year observation
Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome Trust-MRC; Institute of Metabolic Science, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK
Queen Mary University of London, London, UK
Mon 13 12:10
OP1.1
Gene methylation status contributes to delayed puberty
Queen Mary University of London, London, UK
University of Oxford, Oxford, UK
University of Birmingham, Birmingham, UK
Yong Loo Lin School of Medicine, Singapore, UK
Tue 14 15:45
OC7.4
The Effectiveness of Radioactive Iodine versus Thyroidectomy for Paediatric Grave’s Disease: A systematic review and meta-analysis.
Yong Loo Lin School of Medicine, Singapore, UK
Yong Loo Lin School of Medicine, Singapore, Singapore
School of Medicine, University of Leeds, Leeds, UK
Mon 13 15:30
OC3.5
The effects of biochemical control and Arthropathy on Quality of Life in patients with Acromegaly: a cross-sectional study
School of Medicine, University of Leeds, Leeds, UK
Manchester University, Manchester, UK
Tue 14 15:15
OC7.2
Examining latest costs and prescribing on Liothyronine (T3) by dose levels with respect to the 2017 Competition and Market Authority (CMA) investigation into liothyronine prices and the implementation of 2023 British Thyroid Association (BTA) guidance for appropriate patients suggesting Liothyronine daily dose levels of 5-10mcg at possible split dose twice day.
Res Consortium, Andover, UK
Manchester University, Manchester, UK
Wed 15 11:24
ENS8.6
Liothyronine prescribing in England: Is it driven by prescribing costs or clinical need?
Manchester University, Manchester, UK
University of Cambridge, Cambridge, UK
The Christie NHS Foundation Trust, Manchester, UK
Mon 13 11:25
ENS3.2
Update on the Manchester BRC LWBC research theme, Improving Bone Health in Oncology Patients
The Christie NHS Foundation Trust, Manchester, UK
University of , Edinburgh, UK
Tue 14 14:04
OP5.4
Adrenal responses with peak and cumulative hyperthermia from marathon running
University of , Edinburgh, UK
University of Manchester, Manchester, UK
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 15 11:20
RET1.2
Current understanding of RET genotype-phenotype correlation
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 15 12:55
OP7.1
Investigating the functional kinome in Multiple Endocrine Neoplasia Type 2
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Imperial College London, London, UK
Tue 14 07:50
GU1.2
The treatment of female hypogonadism
Imperial College London, London, UK
Imperial College London, London, UK
Wed 15 14:50
ECS1.3
'Comment or no comment'?
Imperial College London, London, UK
Spire Manchester Hospital, Manchester, UK
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, N Ireland, UK, Belfast, UK
Tue 14 13:29
OP4.4
Incidental thyroid nodules on CT Angiography in patients presenting with acute stroke: incidence and clinical outcomes from a regional stroke centre
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, N Ireland, UK, Belfast, UK
Harvard Medical School
Tue 14 09:00
PL5.1
Plenary 5: Pseudohypoparathyroidism: multiple genetic and epigenetic changes within the GNAS locus cause distinct disease variants
Harvard Medical School
Birmingham, UK
Mon 13 10:00
HDI1.2
Wed 15 10:50
ENS7.1
Wed 15 11:30
ENS7.5
University of Birmingham, Birmingham, UK
Tue 14 13:20
TN1.2
Measuring the Impact of simulation-based learning
University of Birmingham, Birmingham, UK
King’s College London, London, UK
Mon 13 10:45
BSW1.3
Accounting for sex differences in experimental design
King’s College London, London, UK
University of Oxford, Oxford, UK
Tue 14 09:35
EC1.1
Early Career Lecture Basic Science: Investigating the retinoic acid pathway as a potential therapeutic target for skeletal dysplasia syndromes
University of Oxford, Oxford, UK
Sheffield, UK
Mon 13 11:50
ENS1.4
University College London Hospitals NHS Foundation Trust, London, UK
Tue 14 11:30
NS1.1
Primary Hyperparathyroidism: Can innovative technologies improve current diagnostic and therapeutic pathways?
University College London Hospitals NHS Foundation Trust, London, UK
Wed 15 15:50
RET2.3
Surgical Precision for RET-related tumour syndromes in the era of Precision Medicine
University College London Hospitals NHS Foundation Trust, London, UK
Western General Hospital, Edinburgh, UK
Tue 14 17:00
HDI2.1
Monitor hormone replacement in primary adrenal insufficiency?
Western General Hospital, Edinburgh, UK
Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, UK
Mon 13 13:09
OP3.4
Exploring the sexual dimorphic development of human external genitalia
Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, UK
Science Media Centre
Leicester, UK
Royal Alexandra Hospital, Paisley, UK
Wed 15 12:36
OP6.3
A case of hypophosphatasia presenting during pregnancy
Royal Alexandra Hospital, Paisley, UK
University of Oxford Hospitals, Oxford, UK
University of Oxford, Oxford, UK
Cardiff University School of Medicine, Cardiff, UK
Wed 15 09:15
S5.1
Thyrotropin Receptor Autoantibodies, stimulating, blocking or neutral
Cardiff University School of Medicine, Cardiff, UK
DefiniGEN Ltd., Cambridge, UK
Mon 13 13:09
OP2.4
iPSC-derived hepatocytes as a novel tool for Ornithine Transcarbamylase Deficiency (OTCD) modelling and drug screening.
DefiniGEN Ltd., Cambridge, UK
University of Cambridge and Cambridge University Hospitals, Cambridge , UK
Mon 13 12:18
OP1.2
Optimisation of molecular imaging for pituitary tumours using a radioactive phantom
University of Cambridge and Cambridge University Hospitals, Cambridge , UK
Université catholique de Louvain, Belgium
University of Birmingham, Birmingham, UK
Mon 13 15:45
OC2.6
A critical role for the proto-oncogene PBF in regulating cellular adhesion and motility in thyroid cancer
University of Birmingham, Birmingham, UK
Massachusetts General Hospital, Boston, USA
Royal Free Hospital, London, UK
Mon 13 14:45
OC2.2
Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, UK
Tue 14 18:00
BSW2.3
How to make the most of protein structural data to interpret consequences of genetic variants
Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, UK
Ninewells Hospital and Medical school, University of Dundee, Dundee
Wed 15 09:15
S4.1
Ageing and sperm health
Ninewells Hospital and Medical school, University of Dundee, Dundee
Wellcome Sanger Institute, Cambridge, UK
Tue 14 10:25
EC1.4
CEJF Best Abstract Basic: Single-Cell Analysis for the Human Developing Thyroid Uncovers Thyrocyte Heterogeneity and Active Interactions During Development
Wellcome Sanger Institute, Cambridge, UK
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Trust, Oxford, UK
Mon 13 12:45
OP3.1
ARE WE GIVING ENOUGH ATTENTION TO BLOOD PRESSURE CONTROL IN TURNER SYNDROME? : DATA FROM THE INTERNATIONAL TURNER SYNDROME (I-TS) REGISTRY
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Trust, Oxford, UK
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Tue 14 15:30
NS2.2
Thyroid Cancer over view and the vital role a specialist nurse can play in facilitating follow up
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Mon 13 12:53
OP3.2
Abnormal uterine bleeding (AUB) and COVID-19: investigating associations and potential mechanisms.
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
University of Birmingham , Birmingham, UK
Wed 15 08:00
PL7.1
Plenary 7: Understanding, manipulating and exploiting the sodium iodide symporter
University of Birmingham , Birmingham, UK
Guys & St Thomas NHS Trust, London, UK
Wed 15 10:50
ENS6.1
GLP-1 analogues for obesity: how do we prioritise patients?
Glasgow, UK
University of Exeter, Exeter, United Kingdom
London, United Kingdom
Guys & St Thomas NHS Trust, London, UK
University of Medicine and Health Sciences, Dublin, Ireland
Tue 14 12:00
S3.2
The role of androgens in endocrine therapy-resistant post menopausal breast cancer
University of Medicine and Health Sciences, Dublin, Ireland
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Mon 13 14:30
OC4.1
Unsupervised steroid metabolome cluster analysis to dissect androgen excess and metabolic dysfunction in 488 women with polycystic ovary syndrome – results from the prospective DAISy-PCOS study.
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, UK
Mon 13 15:15
OC3.4
Characterisation of serum prolactin and mammary prolactin sensitivity at the onset of human lactation
Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, UK
UCLH London, London, UK
Tue 14 17:15
NS3.3
Nurse Survey results
UCLH London, London, UK
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
University of Pretoria, South Africa
Tue 14 17:30
LOE1.2
Imperial College London, London, UK
Mon 13 15:15
OC4.4
Intranasal Kisspeptin: A Novel, Effective and Non-Invasive Approach to Stimulate Reproductive Hormones in Patients with Reproductive Disorders
Imperial College London, London, UK
Tue 14 09:55
EC1.2
Early Career Lecture Clinical: Can a KISS Treat Low Sexual Desire in Men?
Imperial College London, London, UK
Imperial College London, London, UK
Newcastle University, Newcastle, UK
Mon 13 10:15
HDI1.3
Chelsea and Westminster Hospital, London, UK
Mon 13 11:40
ENS3.3
Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer.
The Christie NHS Foundation Trust, Manchester, UK
Chelsea and Westminster Hospital, London, UK
Spire Manchester Hospital, Manchester, UK
Wed 15 14:50
ECS1.3
'Comment or no comment'?
Imperial College London, London, UK
Spire Manchester Hospital, Manchester, UK
Imperial College London, London, UK
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 13 11:00
HDI1.6
Recognise and manage adrenal insufficiency in patients receving immunotherapy?
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
London, United Kingdom
Queen Elizabeth Hospital, Gateshead foundation NHS trust, Gateshead, UK
Tue 14 13:21
OP4.3
Prevalence, predictors and rhythm outcome of Atrial fibrillation (AF) in patients with Graves hyperthyroidism
Queen Elizabeth Hospital, Gateshead foundation NHS trust, Gateshead, UK
Imperial College, London, UK
Tue 14 13:40
TN1.4
New Teaching and Assessment Practices in an Undergraduate Medicine Intercalated BSc in Endocrinology
Imperial College, London, UK
University of Oxford, Oxford, UK
Tue 14 16:15
OC6.6
Low carbohydrate diets in Type 1 diabetes – defining the degree of glycaemic control and nutritional ketosis
University of Oxford, Oxford, UK
Cambridge University Hospitals NHS Foundation Trust, Cambridge , UK
Tue 14 14:20
MTE3.1
Primary Hyperaldosteronism
Cambridge University Hospitals NHS Foundation Trust, Cambridge , UK
University of Dundee, Dundee, UK
Wed 15 13:35
PL9.1
Plenary 9: Precision Medicine in Diabetes: From Discovery to Implementation
University of Dundee, Dundee, UK
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Tue 14 13:48
OP5.2
Sex differences in the hypothalamus-pituitary-adrenal axis during stress
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Norwich Medical School, Norwich, UK
Wed 15 12:20
OP6.1
Sclerostin but not Dickkopf-related protein 1 predicts bone mass and markers of bone turnover in older adults
Norwich Medical School, Norwich, UK
Wed 15 12:28
OP6.2
Measuring FGF23 in patients treated with burosumab
Norwich Medical School, Norwich, UK
Centre for Endocrinology, William Harvey Research Institute, London, UK
Tue 14 15:15
OC5.2
Gain-of-function mutation F278C in MC2R results in reduced beta-1-arrestin recruitment and increased cAMP implicating impairment of S280 phosphorylation.
Centre for Endocrinology, William Harvey Research Institute, London, UK
University of Birmingham, Birmingham, UK
Tue 14 15:00
OC5.1
Urine steroid metabolomics as a diagnostic tool in endocrine hypertension
University of Birmingham, Birmingham, UK
British Thyroid Foundation, Harrogate , UK
Imperial College London, London, UK
Tue 14 07:50
GU1.2
The treatment of female hypogonadism
Imperial College London, London, UK
Imperial College London, London, UK
Tue 14 10:55
OCP1.1
Pubertal-induction in the 21st century – time to set aside historic paediatric dogmas
Imperial College London, London, UK
Queen Mary University of London, London, UK
Mon 13 14:30
OC3.1
CDC42: a potential therapeutic target of clinically non-functioning pituitary neuroendocrine tumours
Queen Mary University of London, London, UK
University of Birmingham, Birmingham, UK
Mon 13 14:30
OC2.1
Manipulating NIS endocytosis as a druggable target to enhance radioiodide uptake and prognostic indictor of thyroid cancer recurrence
University of Birmingham, Birmingham, UK
Cardiff University, United Kingdom
Mon 13 11:50
ENS1.4
Ohio State University, Columbus, Ohio, USA
Tue 14 14:20
MTE4..1
Mid Cheshire Hospitals NHS Foundation Trust
Oxford, UK
School of Medicine, University of Leeds, Leeds, UK
Mon 13 12:26
OP1.3
Biochemical control does not improve functional impairment in people with acromegaly
School of Medicine, University of Leeds, Leeds, UK
Glasgow, UK
Wed 15 10:50
ENS6.1
GLP-1 analogues for obesity: how do we prioritise patients?
Glasgow, UK
University of Exeter, Exeter, United Kingdom
London, United Kingdom
Guys & St Thomas NHS Trust, London, UK
Institute of Bioengineering, Lausanne, Switzerland
Wed 15 08:30
PL8.1
Plenary 8: Bile acid signaling: connecting nutrition to metabolism
Institute of Bioengineering, Lausanne, Switzerland
Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
Mon 13 14:45
OC4.2
Maternal chronodisruption during gestation affects clock functioning in fetal tissues in a sex-dependent manner via melatonin-independent pathways
Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
University of Edinburgh, Edinburgh, UK
Tue 14 12:30
S2.2
How adipose tissue sometimes fails to cope with the pressure
University of Edinburgh, Edinburgh, UK
IMSR, University of Birmingham, Birmingham, UK
Mon 13 15:00
OC1.3
The role of glucocorticoid metabolism in the skeletal pathophysiology of chronic kidney disease
IMSR, University of Birmingham, Birmingham, UK
Imperial College London, London, UK
Mon 13 15:00
OC3.3
A mutagenesis-based approach to stabilise D2 dopamine G protein-coupled receptor homomers
Imperial College London, London, UK
County Durham and Darlington Foundation Trust, Darlington, UK
Wed 15 12:44
OP6.4
HDR syndrome (hypoparathyroidism, deafness and renal dysplasia) Unveiled: A rare cause of profound hypocalcaemia and seizure.
County Durham and Darlington Foundation Trust, Darlington, UK
University College London Hospital, London, UK
Mon 13 09:25
WIN1.2
What is new in Clinical endocrinology research?
University College London Hospital, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Tue 14 16:00
OC7.5
Thyroid Cancer Referral Pathways: Findings from an Inner-City Tertiary Thyroid Centre
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Oxford Centre for Diabetes, Endocrinology, and Metabolism; University of Oxford, Oxford, UK
Mon 13 12:53
OP2.2
An Acute Upregulation of Hepatic De Novo Lipogenesis Does Not Attenuate the Partitioning of Polyunsaturated Fatty Acids into Oxidation Pathways
Oxford Centre for Diabetes, Endocrinology, and Metabolism; University of Oxford, Oxford, UK
Queen Mary University of London, London, UK
Tue 14 13:56
OP5.3
Adrenal insufficiency can be associated with biallelic mutations in porphyria genes
Queen Mary University of London, London, UK
Queen Mary University of London, London, UK
University of Aberdeen
Mon 13 17:10
PL3.1
Plenary 3: The surprising impact of very low protein diets on body weight regulation
University of Aberdeen
University of Cambridge, Cambridge
Res Consortium, Andover, UK
Tue 14 15:15
OC7.2
Examining latest costs and prescribing on Liothyronine (T3) by dose levels with respect to the 2017 Competition and Market Authority (CMA) investigation into liothyronine prices and the implementation of 2023 British Thyroid Association (BTA) guidance for appropriate patients suggesting Liothyronine daily dose levels of 5-10mcg at possible split dose twice day.
Res Consortium, Andover, UK
Manchester University, Manchester, UK
Imperial College London, London, United Kingdom
Tue 14 07:50
GU1.1
The diagnosis and management of post bariatric surgery hypoglycaemia
Imperial College London, London, United Kingdom
Cardiff University, Cardiff, UK
Wed 15 10:50
ENS8.1
Wed 15 11:30
ENS8.7
University of Oxford, Oxford, UK
Mon 13 10:30
HDI1.4
Screen for NAFLD and its progression in patients with diabetes?
University of Oxford, Oxford, UK
University of Birmingham, Birmingham, UK
Mon 13 15:00
OC2.3
Cellular landscape of adrenocortical carcinomas at single-nuclei resolution
University of Birmingham, Birmingham, UK
University of Michigan, Michigan
Wed 15 11:40
MTE6.1
New Tools for the Clinical Management of Congenital Adrenal Hyperplasia
University of Michigan, Michigan
University of Exeter, Exeter, UK
Tue 14 12:00
S2.3
Using genetics to disentangle causal relationships between psychosocial stressors and diabetes
University of Exeter, Exeter, UK
University of Bristol, Bristol, UK
Mon 13 12:34
OP1.4
Ambulatory dynamic assessment in endocrinology: Insights and possibilities
University of Bristol, Bristol, UK
Exeter
Imperial College London, London, UK
Mon 13 15:30
OC4.5
Luteinising hormone receptor signalling is reliant on formation of distinct multi-receptor complexes
Imperial College London, London, UK
Imperial College School of Medicine, London, UK
Wed 15 13:19
OP8.4
Fixing Black Holes in Traditional Clinical Training: 360o Virtual Reality Emergency Simulations
Imperial College School of Medicine, London, UK
Sheffield, UK
Tue 14 17:45
HDI2.4
School of Biological and Behavioural Sciences, Queen Mary University of London, London, UK
Mon 13 15:45
OC3.6
Aryl hydrocarbon receptor-interacting protein (aip) loss causes failure-to-thrive and cardiac defects in zebrafish
School of Biological and Behavioural Sciences, Queen Mary University of London, London, UK
Nuffield Health Oxford Hospital, Oxford, United Kingdom
Wed 15 11:05
ENS7.4
International consensus guidelines on prolactin-secreting pituitary adenomas
Nuffield Health Oxford Hospital, Oxford, United Kingdom
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Mon 13 12:53
OP3.2
Abnormal uterine bleeding (AUB) and COVID-19: investigating associations and potential mechanisms.
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
University of Exeter, Exeter, UK
Wed 15 13:11
OP7.3
Penetrance of MEN2A-causing RET mutations in clinically unselected population is very low – important implications for clinical practice.
University of Exeter, Exeter, UK
Newcastle University, Newcastle upon Tyne, UK
Wed 15 11:16
ENS8.5
King's College London, London, UK
Mon 13 15:45
OC4.6
Tool development: Characterization of novel follicle-stimulating hormone receptor (FSHR) Inhibitors
King's College London, London, UK
Imperial College London NHS Trust, London, UK
Tue 14 13:05
OP4.1
Management of thyroid nodules in patient with phosphatase and tensin homolog gene (PTEN) mutation
Imperial College London NHS Trust, London, UK
The London Clinic, London, UK
Nottingham Trent University, Nottingham, UK
Tue 14 15:15
OC6.2
An HIF-fective Connection? Unravelling the link between HIF1α, Diabetic Neuropathy, and Obesity.
Nottingham Trent University, Nottingham, UK
Université Paris Cité, Paris , France
Workshop
8
Oral
15
Expert
0
Plenary
12
Catering and Social
11
Nurse
5
Other
25
Symposium
12
No Session Type
0
Mon 13 09:10
WIN1.1
Mon 13 09:25
WIN1.2
What is new in Clinical endocrinology research?
University College London Hospital, London, UK
Mon 13 10:45
BSW1.3
Accounting for sex differences in experimental design
King’s College London, London, UK
Mon 13 09:45
CMW1.1
Tue 14 17:00
BSW2.1
How to use structural biology to advance your endocrine research
MRC Laboratory of Molecular Biology , Cambridge
Tue 14 18:00
BSW2.3
How to make the most of protein structural data to interpret consequences of genetic variants
Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, UK
Tue 14 17:00
LOE1.1
Steroids and the Cardiovascular System
University of Edinburgh, Edinburgh, United Kingdom
Tue 14 17:30
LOE1.2
Wed 15 14:50
ECS1.1
Listening and learning - how podcasting is more than a communication tool
Government Office for Science
Wed 15 14:50
ECS1.3
'Comment or no comment'?
Imperial College London, London, UK
Spire Manchester Hospital, Manchester, UK
Wed 15 14:50
ESD1.1
Wed 15 15:50
RET2.3
Surgical Precision for RET-related tumour syndromes in the era of Precision Medicine
University College London Hospitals NHS Foundation Trust, London, UK
Mon 13 12:10
OP1.1
Gene methylation status contributes to delayed puberty
Queen Mary University of London, London, UK
Mon 13 12:18
OP1.2
Optimisation of molecular imaging for pituitary tumours using a radioactive phantom
University of Cambridge and Cambridge University Hospitals, Cambridge , UK
Mon 13 12:26
OP1.3
Biochemical control does not improve functional impairment in people with acromegaly
School of Medicine, University of Leeds, Leeds, UK
Mon 13 12:34
OP1.4
Ambulatory dynamic assessment in endocrinology: Insights and possibilities
University of Bristol, Bristol, UK
Mon 13 12:45
OP2.1
Insulin resistance in macrophages impacts cholesterol biosynthesis and interferon gene expression and reduces foam cell formation capacity
Royal Veterinary College, London, UK
Mon 13 12:53
OP2.2
An Acute Upregulation of Hepatic De Novo Lipogenesis Does Not Attenuate the Partitioning of Polyunsaturated Fatty Acids into Oxidation Pathways
Oxford Centre for Diabetes, Endocrinology, and Metabolism; University of Oxford, Oxford, UK
Mon 13 13:01
OP2.3
Vitamin B12 deficiency alters leptin DNA methylation and lipid metabolism in the human placenta
Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK
Mon 13 13:09
OP2.4
iPSC-derived hepatocytes as a novel tool for Ornithine Transcarbamylase Deficiency (OTCD) modelling and drug screening.
DefiniGEN Ltd., Cambridge, UK
Mon 13 12:45
OP3.1
ARE WE GIVING ENOUGH ATTENTION TO BLOOD PRESSURE CONTROL IN TURNER SYNDROME? : DATA FROM THE INTERNATIONAL TURNER SYNDROME (I-TS) REGISTRY
Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Trust, Oxford, UK
Mon 13 12:53
OP3.2
Abnormal uterine bleeding (AUB) and COVID-19: investigating associations and potential mechanisms.
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Mon 13 13:09
OP3.4
Exploring the sexual dimorphic development of human external genitalia
Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Foresterhill, Aberdeen, UK
Mon 13 14:30
OC1.1
Vitamin D metabolites are associated with overuse musculoskeletal and bone stress injury in young adults
University of East Anglia, Norwich, UK
Mon 13 15:00
OC1.3
The role of glucocorticoid metabolism in the skeletal pathophysiology of chronic kidney disease
IMSR, University of Birmingham, Birmingham, UK
Mon 13 15:30
OC1.5
CTNNB1 pathogenic variants can cause an autosomal dominant osteoporosis-pseudoglioma-like syndrome: a new form of osteogenesis imperfecta?
King’s College London, London, UK
Mon 13 15:45
OC1.6
Management of Vitamin D Deficiency in Primary Hyperparathyroidism: A Systematic Literature Review and Meta-Analysis
University of South Wales, Cardiff, UK
Mon 13 14:30
OC2.1
Manipulating NIS endocytosis as a druggable target to enhance radioiodide uptake and prognostic indictor of thyroid cancer recurrence
University of Birmingham, Birmingham, UK
Mon 13 14:45
OC2.2
Mon 13 15:00
OC2.3
Cellular landscape of adrenocortical carcinomas at single-nuclei resolution
University of Birmingham, Birmingham, UK
Mon 13 15:15
OC2.4
Communication Between Peri-Prostatic Adipocytes and Epithelial Cells Drives Prostate Cancer Aggressivity in Obese Men
Imperial College London, London, UK
Mon 13 15:30
OC2.5
Androgen Mediated Metabolic Perturbation in Endocrine Resistant Breast Cancer
Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland (RCSI), Dublin, UK
Mon 13 15:45
OC2.6
A critical role for the proto-oncogene PBF in regulating cellular adhesion and motility in thyroid cancer
University of Birmingham, Birmingham, UK
Mon 13 14:30
OC3.1
CDC42: a potential therapeutic target of clinically non-functioning pituitary neuroendocrine tumours
Queen Mary University of London, London, UK
Mon 13 14:45
OC3.2
Long-term outcomes of non-operated non-functioning pituitary macroadenomas – results from the UK NFPA consortium
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Mon 13 15:00
OC3.3
A mutagenesis-based approach to stabilise D2 dopamine G protein-coupled receptor homomers
Imperial College London, London, UK
Mon 13 15:15
OC3.4
Characterisation of serum prolactin and mammary prolactin sensitivity at the onset of human lactation
Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, UK
Mon 13 15:30
OC3.5
The effects of biochemical control and Arthropathy on Quality of Life in patients with Acromegaly: a cross-sectional study
School of Medicine, University of Leeds, Leeds, UK
Mon 13 15:45
OC3.6
Aryl hydrocarbon receptor-interacting protein (aip) loss causes failure-to-thrive and cardiac defects in zebrafish
School of Biological and Behavioural Sciences, Queen Mary University of London, London, UK
Mon 13 14:30
OC4.1
Unsupervised steroid metabolome cluster analysis to dissect androgen excess and metabolic dysfunction in 488 women with polycystic ovary syndrome – results from the prospective DAISy-PCOS study.
MRC Laboratory of Medical Sciences and Imperial College London, Birmingham, UK
Mon 13 14:45
OC4.2
Maternal chronodisruption during gestation affects clock functioning in fetal tissues in a sex-dependent manner via melatonin-independent pathways
Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
Mon 13 15:00
OC4.3
Self-administering post-cycle therapy is associated with biochemical gonadal recovery in men stopping anabolic-androgenic steroid use.
Imperial College London, London, UK
Mon 13 15:15
OC4.4
Intranasal Kisspeptin: A Novel, Effective and Non-Invasive Approach to Stimulate Reproductive Hormones in Patients with Reproductive Disorders
Imperial College London, London, UK
Mon 13 15:30
OC4.5
Luteinising hormone receptor signalling is reliant on formation of distinct multi-receptor complexes
Imperial College London, London, UK
Mon 13 15:45
OC4.6
Tool development: Characterization of novel follicle-stimulating hormone receptor (FSHR) Inhibitors
King's College London, London, UK
Tue 14 13:05
OP4.1
Management of thyroid nodules in patient with phosphatase and tensin homolog gene (PTEN) mutation
Imperial College London NHS Trust, London, UK
Tue 14 13:13
OP4.2
Primary thyroid sarcoma: a case report
Mary Mediatrix Medical Center, Lipa City, Philippines
Tue 14 13:21
OP4.3
Prevalence, predictors and rhythm outcome of Atrial fibrillation (AF) in patients with Graves hyperthyroidism
Queen Elizabeth Hospital, Gateshead foundation NHS trust, Gateshead, UK
Tue 14 13:29
OP4.4
Incidental thyroid nodules on CT Angiography in patients presenting with acute stroke: incidence and clinical outcomes from a regional stroke centre
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, N Ireland, UK, Belfast, UK
Tue 14 13:40
OP5.1
Nocturnal Metyrapone Administration for Cortisol Suppression in MACS: Tolerability and Impact on Metabolic Outcomes
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Tue 14 13:48
OP5.2
Sex differences in the hypothalamus-pituitary-adrenal axis during stress
Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Tue 14 13:56
OP5.3
Adrenal insufficiency can be associated with biallelic mutations in porphyria genes
Queen Mary University of London, London, UK
Queen Mary University of London, London, UK
Tue 14 14:04
OP5.4
Adrenal responses with peak and cumulative hyperthermia from marathon running
University of , Edinburgh, UK
Tue 14 15:00
OC5.1
Urine steroid metabolomics as a diagnostic tool in endocrine hypertension
University of Birmingham, Birmingham, UK
Tue 14 15:15
OC5.2
Gain-of-function mutation F278C in MC2R results in reduced beta-1-arrestin recruitment and increased cAMP implicating impairment of S280 phosphorylation.
Centre for Endocrinology, William Harvey Research Institute, London, UK
Tue 14 15:45
OC5.4
Mild weight loss and activation of RAAS in gene-edited mice with a E958A knock-in mutation in the AF2-LBD domain of the mineralocorticoid receptor gene
Monash University, Melbourne, Australia
Tue 14 16:00
OC5.5
Identification of MicroRNAs Targeting the Mineralocorticoid Receptor with Therapeutic Potential in Vascular Cognitive Impairment
University of Glasgow, Glasgow, UK
Tue 14 16:15
OC5.6
11βHSD1 inhibition improves cardiac function compared to standard therapy in a translational pig mode through regulation of extracellular matrix
University of Edinburgh, Edinburgh, UK
Tue 14 15:00
OC6.1
Reduction of SGLT2 protein levels inhibits cortisol secretion through regulation of cytokine secretion
Imperial College London, London, United Kingdom
Tue 14 15:15
OC6.2
An HIF-fective Connection? Unravelling the link between HIF1α, Diabetic Neuropathy, and Obesity.
Nottingham Trent University, Nottingham, UK
Tue 14 15:30
OC6.3
Sex hormone contribution to sex differences in a mouse model of beta cell endoplasmic reticulum (ER) stress.
King's College London, London, UK
Tue 14 15:45
OC6.4
Human brown adipose tissue activity is regulated by the parasympathetic nervous system
University of Edinburgh, Edinburgh, UK
Tue 14 16:00
OC6.5
Increased risk of obesity programmed by in utero exposure to maternal obesity: the effects of miR-505-5p in the hypothalamus.
Centre for Health and Life Sciences- Coventry University, Coventry, UK
Tue 14 16:15
OC6.6
Low carbohydrate diets in Type 1 diabetes – defining the degree of glycaemic control and nutritional ketosis
University of Oxford, Oxford, UK
Tue 14 15:00
OC7.1
A copper-based metabolite of disulfiram upregulates sodium iodide symporter (NIS) gene expression to enhance thyroidal uptake of radionuclides in vivo
University of Birmingham, Birmingham, UK
Tue 14 15:15
OC7.2
Examining latest costs and prescribing on Liothyronine (T3) by dose levels with respect to the 2017 Competition and Market Authority (CMA) investigation into liothyronine prices and the implementation of 2023 British Thyroid Association (BTA) guidance for appropriate patients suggesting Liothyronine daily dose levels of 5-10mcg at possible split dose twice day.
Res Consortium, Andover, UK
Manchester University, Manchester, UK
Tue 14 15:30
OC7.3
Influence of tyrosine availability on TSH-dependent cell proliferation and gene transcription in rat FRTL-5 thyroid cells
Royal Veterinary College, London, UK
Tue 14 15:45
OC7.4
The Effectiveness of Radioactive Iodine versus Thyroidectomy for Paediatric Grave’s Disease: A systematic review and meta-analysis.
Yong Loo Lin School of Medicine, Singapore, UK
Yong Loo Lin School of Medicine, Singapore, Singapore
Tue 14 16:00
OC7.5
Thyroid Cancer Referral Pathways: Findings from an Inner-City Tertiary Thyroid Centre
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Tue 14 16:15
OC7.6
Shallow Whole Genome Sequencing (sWGS) as an Aiding Tool in Monitoring of Thyroid Cancer
University of Leicester, Leicester, UK
Wed 15 12:20
OP6.1
Sclerostin but not Dickkopf-related protein 1 predicts bone mass and markers of bone turnover in older adults
Norwich Medical School, Norwich, UK
Wed 15 12:28
OP6.2
Measuring FGF23 in patients treated with burosumab
Norwich Medical School, Norwich, UK
Wed 15 12:36
OP6.3
A case of hypophosphatasia presenting during pregnancy
Royal Alexandra Hospital, Paisley, UK
Wed 15 12:44
OP6.4
HDR syndrome (hypoparathyroidism, deafness and renal dysplasia) Unveiled: A rare cause of profound hypocalcaemia and seizure.
County Durham and Darlington Foundation Trust, Darlington, UK
Wed 15 12:55
OP7.1
Investigating the functional kinome in Multiple Endocrine Neoplasia Type 2
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 15 13:03
OP7.2
Peptide Receptor Radiotherapy (PRRT) for well- differentiated metastatic Paraganglioma and Phaeochromocytomas (PPGL).
Guy's and St Thomas' Trust, London, UK
Wed 15 13:11
OP7.3
Penetrance of MEN2A-causing RET mutations in clinically unselected population is very low – important implications for clinical practice.
University of Exeter, Exeter, UK
Wed 15 13:19
OP7.4
Primary ovarian failure after 131I-metaiodobenzylguanide (MIBG) therapy
King's College Hospital, London, UK
Wed 15 12:55
OP8.1
Real-world experience with 11C-methionine PET co-registered with MRI in the management of acromegaly – Insights from a single reference centre 12 year observation
Cambridge Endocrine Molecular Imaging Group, Metabolic Research Laboratories, Wellcome Trust-MRC; Institute of Metabolic Science, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK
Wed 15 13:03
OP8.2
Subcutaneous Levothyroxine as an alternative long-term treatment for refractory hypothyroidism: A case report
George Elliot Hospital, Nuneaton, UK
Wed 15 13:11
OP8.3
Unsuspected autonomous adrenal cortisol excess and primary aldosteronism accurately diagnosed by NP59 scanning after discordant adrenal vein sampling
Cumming School of Medicine, University of Calgary, Calgary, Canada
Wed 15 13:19
OP8.4
Fixing Black Holes in Traditional Clinical Training: 360o Virtual Reality Emergency Simulations
Imperial College School of Medicine, London, UK
Mon 13 13:25
PL1.1
Plenary 1: Are we restoring thyroid hormone signaling in patients with hypothyroidism?
University of Chicago, Chicago, USA
Mon 13 13:55
PL2.1
Plenary 2: With a little help from my friends: Melanocortin Receptors and their accessory proteins in health and disease
Queen Mary University of London , London, UK
Mon 13 16:25
PR1.1
Mon 13 17:10
PL3.1
Plenary 3: The surprising impact of very low protein diets on body weight regulation
University of Aberdeen
Tue 14 08:30
PL4.1
Plenary 4: Living with Polycystic Ovary Syndrome: Concepts and Consequences
Imperial College , London, UK
Tue 14 09:00
PL5.1
Plenary 5: Pseudohypoparathyroidism: multiple genetic and epigenetic changes within the GNAS locus cause distinct disease variants
Harvard Medical School
Wed 15 08:00
PL7.1
Plenary 7: Understanding, manipulating and exploiting the sodium iodide symporter
University of Birmingham , Birmingham, UK
Wed 15 08:30
PL8.1
Plenary 8: Bile acid signaling: connecting nutrition to metabolism
Institute of Bioengineering, Lausanne, Switzerland
Wed 15 13:35
PL9.1
Plenary 9: Precision Medicine in Diabetes: From Discovery to Implementation
University of Dundee, Dundee, UK
Tue 14 11:30
NS1.1
Primary Hyperparathyroidism: Can innovative technologies improve current diagnostic and therapeutic pathways?
University College London Hospitals NHS Foundation Trust, London, UK
Tue 14 14:20
MTE3.1
Primary Hyperaldosteronism
Cambridge University Hospitals NHS Foundation Trust, Cambridge , UK
Tue 14 15:30
NS2.2
Thyroid Cancer over view and the vital role a specialist nurse can play in facilitating follow up
Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Tue 14 17:05
NS3.2
Tue 14 17:15
NS3.3
Nurse Survey results
UCLH London, London, UK
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Mon 13 10:00
HDI1.2
Mon 13 10:15
HDI1.3
Mon 13 10:30
HDI1.4
Screen for NAFLD and its progression in patients with diabetes?
University of Oxford, Oxford, UK
Mon 13 11:00
HDI1.6
Recognise and manage adrenal insufficiency in patients receving immunotherapy?
Leeds Teaching Hospitals NHS Trust, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Mon 13 11:40
ENS1.3
I-CAH: a platform for data collection and network activities
Glasgow, United Kingdom
Mon 13 11:50
ENS1.4
Mon 13 11:50
ENS2.3
Glucocorticoid-induced osteoporosis: the state of the art in the era of anabolics
University of Cambridge , Cambridge , UK
Mon 13 11:25
ENS3.2
Update on the Manchester BRC LWBC research theme, Improving Bone Health in Oncology Patients
The Christie NHS Foundation Trust, Manchester, UK
Mon 13 11:40
ENS3.3
Diagnostic criteria and proposed management of immune-related endocrinopathies following immune checkpoint inhibitor therapy for cancer.
The Christie NHS Foundation Trust, Manchester, UK
Chelsea and Westminster Hospital, London, UK
Mon 13 11:55
ENS3.4
Stroke Risk in Childhood, Adolescent, and Young Adult (CAYA) Cancer Survivors who Received Cranial Radiotherapy- results of local audit.
Université de Montréal , Montréal , Canada
Mon 13 11:50
ENS4.3
Tue 14 07:50
GU1.1
The diagnosis and management of post bariatric surgery hypoglycaemia
Imperial College London, London, United Kingdom
Tue 14 07:50
GU1.2
The treatment of female hypogonadism
Imperial College London, London, UK
Imperial College London, London, UK
Tue 14 09:35
EC1.1
Early Career Lecture Basic Science: Investigating the retinoic acid pathway as a potential therapeutic target for skeletal dysplasia syndromes
University of Oxford, Oxford, UK
Tue 14 09:55
EC1.2
Early Career Lecture Clinical: Can a KISS Treat Low Sexual Desire in Men?
Imperial College London, London, UK
Tue 14 10:25
EC1.4
CEJF Best Abstract Basic: Single-Cell Analysis for the Human Developing Thyroid Uncovers Thyrocyte Heterogeneity and Active Interactions During Development
Wellcome Sanger Institute, Cambridge, UK
Tue 14 10:55
TAA1.1
Alex's Osteoblast : Revitalising Teaching During Covid
Imperial College London, London, UK
Tue 14 10:55
OCP1.1
Pubertal-induction in the 21st century – time to set aside historic paediatric dogmas
Imperial College London, London, UK
Tue 14 10:55
ENS5.1
Update on the national registry for phaeochromocytoma and paraganglioma and ACC
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 14 11:05
ENS5.2
Q&A
Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom
Tue 14 13:20
TN1.2
Measuring the Impact of simulation-based learning
University of Birmingham, Birmingham, UK
Tue 14 13:40
TN1.4
New Teaching and Assessment Practices in an Undergraduate Medicine Intercalated BSc in Endocrinology
Imperial College, London, UK
Tue 14 14:20
MTE4..1
Tue 14 17:00
HDI2.1
Monitor hormone replacement in primary adrenal insufficiency?
Western General Hospital, Edinburgh, UK
Tue 14 17:15
HDI2.2
Tue 14 17:30
HDI2.3
De-escalate LT4 therapy in overtreated patients?
Norfolk and Norwich University Hospitals NHS Trust , Norwich, UK
Tue 14 17:45
HDI2.4
Tue 14 18:00
HDI2.5
Do an annual review in a patient with Turner's Syndrome?
endocrinologist at Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
Tue 14 18:15
HDI2.6
Wed 15 10:50
ENS6.1
GLP-1 analogues for obesity: how do we prioritise patients?
Glasgow, UK
University of Exeter, Exeter, United Kingdom
London, United Kingdom
Guys & St Thomas NHS Trust, London, UK
Wed 15 10:50
ENS7.1
Wed 15 11:05
ENS7.4
International consensus guidelines on prolactin-secreting pituitary adenomas
Nuffield Health Oxford Hospital, Oxford, United Kingdom
Wed 15 11:30
ENS7.5
Wed 15 10:50
ENS8.1
Wed 15 11:00
ENS8.3
Wed 15 11:16
ENS8.5
Wed 15 11:24
ENS8.6
Liothyronine prescribing in England: Is it driven by prescribing costs or clinical need?
Manchester University, Manchester, UK
Wed 15 11:30
ENS8.7
Wed 15 11:40
MTE6.1
New Tools for the Clinical Management of Congenital Adrenal Hyperplasia
University of Michigan, Michigan
Tue 14 12:00
S1.2
Targeted therapies for monogenic bone disorders and lessons for commoner disease
King’s College London, London, UK
Tue 14 11:30
S2.1
ER stress in metabolic disease – mechanisms and treatments
Institute for Cardiovascular Prevention
Tue 14 12:00
S2.3
Using genetics to disentangle causal relationships between psychosocial stressors and diabetes
University of Exeter, Exeter, UK
Tue 14 12:30
S2.2
How adipose tissue sometimes fails to cope with the pressure
University of Edinburgh, Edinburgh, UK
Tue 14 11:30
S3.1
Managing impacts of androgen deprivation therapy on bones
University of Sheffield, Sheffield, UK
Tue 14 12:00
S3.2
The role of androgens in endocrine therapy-resistant post menopausal breast cancer
University of Medicine and Health Sciences, Dublin, Ireland
Tue 14 12:30
S3.3
Novel treatment approaches for breast and/or prostate cancer
Imperial College, London, UK
Wed 15 09:15
S4.1
Ageing and sperm health
Ninewells Hospital and Medical school, University of Dundee, Dundee
Wed 15 09:15
S5.1
Thyrotropin Receptor Autoantibodies, stimulating, blocking or neutral
Cardiff University School of Medicine, Cardiff, UK
Wed 15 09:45
S6.2
Reducing the queue for adrenal vein sampling
St Bartholomew’s Hospital, London, UK
Wed 15 11:20
RET1.2
Current understanding of RET genotype-phenotype correlation
Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London , UK
Wed 15 12:00
RET1.4
Life with a RET gene change
Association for Multiple Endocrine Neoplasia Disorders, Southborough, UK
0 result(s) found.